Oncotarget

Meta-Analysis:

The meta and bioinformatics analysis of GRP78 expression in gastric cancer

Hua-Chuan Zheng _, Bao-Cheng Gong and Shuang Zhao

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:73017-73028. https://doi.org/10.18632/oncotarget.20318

Metrics: PDF 1594 views  |   HTML 2245 views  |   ?  


Abstract

Hua-Chuan Zheng1, Bao-Cheng Gong1 and Shuang Zhao1

1Department of Experimental Oncology and Animal Center, Shengjing Hospital of China Medical University, Shenyang 110004, China

Correspondence to:

Hua-Chuan Zheng, email: [email protected]

Keywords: GRP78, gastric cancer, meta analysis, bioinformatics analysis

Received: July 05, 2017     Accepted: August 04, 2017     Published: August 18, 2017

ABSTRACT

GRP78 is a molecular chaperone located in endoplasmic reticulum, and induces folding and assembly of newly-synthesized proteins, proteasome degradation of aberrant proteins, and translocation of secretory proteins, autophagy, and epithelial-mesenchymal transition. We performed a systematic meta- and bioinformatics analysis through multiple online databases up to March 14, 2017. It was found that up-regulated GRP78 expression in gastric cancer, compared with normal mucosa at both protein and mRNA levels (p < 0.05). GRP78 expression was positively correlated with depth of invasion, TNM staging and dedifferentiation of gastric cancer (p < 0.05), while its mRNA expression was negatively correlated with depth of invasion, histological grading and dedifferentiation (p < 0.05). A positive association between GRP78 expression and unfavorable overall survival was found in patients with gastric cancer (p < 0.005). A higher GRP78 mRNA expression was positively correlated with overall and progression-free survival rates of all cancer patients, even stratified by aggressive parameters, or as an independent factor (p < 0.05). These findings indicated that GRP78 expression might be employed as a potential marker to indicate gastric carcinogenesis and subsequent progression, even prognosis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20318